Interim Report 2004/05

	Wanji Pharmaceutical Holdings Limited (0835)

Cover Condensed Consolidated Profit and Loss Account Condensed Consolidated Balance Sheet Condensed Consolidated Cash Flow Statement Condensed Consolidated Statement of Changes in Equity Notes to Condensed Interim Accounts Management Discussion and Analysis Audit Committee Directors' Interests in Securities Shareholders with Notifiable Interests Purchases, Sale or Redemption of Shares Compliance With the Code of Best Practice Publication of Interim Report on the Stock Exchange's Website